FCGR2B and anaphylaxis: When the investigators tested the phenotypes on the FcγRIIb-/- background, protection against anaphylaxis by IgG1 antibodies was no longer observed while IgG1-mediated inhibition of diarrhea was, surprisingly, retained (192).